Industry News/Joint Venture

Exclusive Option Extended for Cancer Alliance

Published in Gene Therapy Weekly, July 17th, 1995

At Corange International's request, GeneMedicine Inc., the Woodlands, Texas, has extended the exclusive option for a potential corporate alliance to develop certain gene medicines for application in the field of cancer until July 17, 1995.

GeneMedicine is developing a new class of pharmaceutical products, "gene medicines," based on two technologies: plasmid gene expression systems and synthetic gene delivery systems. These technologies are designed to control the location and function of therapeutic genes within the body.

GeneMedicine's technologies have potential application in treating a wide range of genetic and acquired diseases and disorders,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (1995-07-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry